Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 19-21 May 2026 – www.ema.europa.eu

22 Mag, 2026

www.ema.europa.eu

CVMP opinions on veterinary medicinal products

The Committee adopted a positive opinion for a marketing authorisation for Nobivac NXT HC, for the active immunisation of cats against feline herpesvirus type 1 and feline calicivirus.

The Committee adopted a positive opinion for a marketing authorisation for Nobivax NXT HCP, for the active immunisation of cats against feline herpesvirus type 1, feline calicivirus and feline panleucopenia virus.

The Committee adopted a positive opinion for a marketing authorisation Nobivac NXT HCPCh for the active immunisation of cats against feline herpesvirus type 1, feline calicivirus, feline panleucopenia virus and Chlamydia felis.

The Committee adopted a positive opinion for a marketing authorisation Poulvac Procerta HVT-ND, for the active immunisation of one-day-old chickens and 18- to 19-day-old embryonated chicken eggs against Marek’s disease and Newcastle disease.

The Committee adopted a positive opinion for a variation for…

Vai all’articolo completo.